- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02644993
Registry for Analysis of Quality of Life, Normal Organ Toxicity and Survival of Pediatric Patients Treated With Proton Therapy
October 12, 2016 updated by: Do Hoon Lim, Samsung Medical Center
The study aim of this study is to evaluate the effect of proton therapy on quality of life and long-term normal tissue toxicities of the pediatric cancer patients.
Based on these results, the predictive model of long-term normal tissue toxicities, survival, and quality of life could be recognized.
Risk-adapted treatment strategy based on the predictive model in pediatric cancer patients could be established.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
400
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Do Hoon Lim, MD, PhD
- Phone Number: 82-2-3410-2612
- Email: dh8.lim@samsung.net
Study Contact Backup
- Name: Jeong Il Yu, MD
- Email: ro.yuji651@gmail.com
Study Locations
-
-
-
Seoul, Korea, Republic of
- Recruiting
- Samsung Medical Center
-
Contact:
- Do Hoon Lim, MD, PhD
- Phone Number: 82-2-3410-2612
- Email: dh8.lim@samsung.net
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- less than 18 years of age
- patient who is planned to receive proton therapy at Samsung Medical Center
- Informed consent
Exclusion Criteria:
- Refuse to participate this cohort study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Proton beam therapy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Quality of Life Questionnaire
Time Frame: within 2 weeks before proton beam therapy
|
within 2 weeks before proton beam therapy
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Quality of Life Questionnaire baseline
Time Frame: within 1 week before proton beam therapy completion
|
within 1 week before proton beam therapy completion
|
Quality of Life Questionnaire
Time Frame: 3-6 months after proton beam therapy
|
3-6 months after proton beam therapy
|
Quality of Life Questionnaire
Time Frame: 1 year after proton beam therapy
|
1 year after proton beam therapy
|
Quality of Life Questionnaire
Time Frame: 3 years after proton beam therapy
|
3 years after proton beam therapy
|
Quality of Life Questionnaire
Time Frame: 5 years after proton beam therapy
|
5 years after proton beam therapy
|
Quality of Life Questionnaire
Time Frame: 10 years after proton beam therapy
|
10 years after proton beam therapy
|
Adverse event
Time Frame: 3-6 months after proton beam therapy
|
3-6 months after proton beam therapy
|
Adverse event
Time Frame: 1 year after proton beam therapy
|
1 year after proton beam therapy
|
Adverse event
Time Frame: 3 years after proton beam therapy
|
3 years after proton beam therapy
|
Adverse event
Time Frame: 5 years after proton beam therapy
|
5 years after proton beam therapy
|
Adverse event
Time Frame: 10 years after proton beam therapy
|
10 years after proton beam therapy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Do Hoon Lim, MD, PhD, Proton therapy center, Samsung Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2015
Primary Completion (Anticipated)
November 1, 2025
Study Registration Dates
First Submitted
December 28, 2015
First Submitted That Met QC Criteria
December 31, 2015
First Posted (Estimate)
January 1, 2016
Study Record Updates
Last Update Posted (Estimate)
October 14, 2016
Last Update Submitted That Met QC Criteria
October 12, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- 2015-10-111
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric Cancer Patients
-
Assiut UniversityRecruitingPediatric Cancer PatientsEgypt
-
Sohag UniversityNot yet recruitingPediatric Patients on HemodialysisEgypt
-
American Regent, Inc.Not yet recruiting
-
Osaka UniversityOsaka City General Hospital; Osaka Women's and Children's Hospital; Hyogo Prefectural... and other collaboratorsRecruitingPediatric Patients After Cardiothoracic SurgeryJapan
-
Memorial Sloan Kettering Cancer CenterCompletedPediatric Patients With Solid TumorsUnited States
-
RenJi HospitalRecruitingPediatric Patients Who Need Liver TransplantationChina
-
Massachusetts General HospitalRecruitingPediatric Patients Treated With Radiation TherapyUnited States
-
Peking UniversityRecruitingDeep Sedation | Pediatric Patients | Dental TreatmentChina
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; Weill Medical College of Cornell UniversityCompleted
-
Yonsei UniversityRecruitingPediatric Patients Receiving Venoarterial Extracorporeal Membrane OxygenationKorea, Republic of
Clinical Trials on Proton therapy
-
Provision Center for Proton TherapyCenter for Biomedical Research, LLCRecruitingProstate CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8United States
-
University of FloridaPatient-Centered Outcomes Research InstituteActive, not recruitingProstate CancerUnited States
-
Technische Universität DresdenGerman Cancer Research Center; National Center for Radiation Research in Oncology...RecruitingNon-Small Cell Lung CancerGermany
-
Emory UniversityNational Cancer Institute (NCI)Not yet recruitingResectable Lung Non-Small Cell CarcinomaUnited States
-
University of AarhusOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; University of Leeds and other collaboratorsRecruitingHepatocellular CarcinomaDenmark
-
Abramson Cancer Center at Penn MedicineActive, not recruiting
-
National Cancer Center, KoreaRecruitingProstate AdenocarcinomaKorea, Republic of
-
Chang Gung Memorial HospitalCompletedHepatocellular Carcinoma | Prostate Cancer | Malignant Glioma | Head and Neck Malignant TumorTaiwan
-
Abramson Cancer Center at Penn MedicineActive, not recruiting